Skip to main content
FlashPoint News
CrimeCuliacán, Sinaloa, Mexico

Inside the Sinaloa Cartel: A Dangerous Fentanyl Lab Revealed

A look into the inner workings of a fentanyl production lab run by the Sinaloa cartel as reported by New York Times journalists in Culiacán, Mexico.

By Natalie Kitroeff, Paulina Villegas and Meridith KohutSource: nytimes.com1 min read
Inside the Sinaloa Cartel: A Dangerous Fentanyl Lab Revealed
Image via nytimes.com

In brief

New York Times reporters provide a shocking glimpse into a fentanyl lab operated by the Sinaloa cartel in Culiacán, Mexico. Witnessing the perilous production process, they detail the deadly environment faced by the cooks who are tasked with fulfilling massive orders for the potent drug. The region has seen significant violence recently as cartel factions clash, exacerbating existing societal issues.

In December, New York Times journalists gained access to a hidden fentanyl lab in Culiacán, Sinaloa, revealing an operational timeline of the production of the dangerous narcotic. They describe the scene as a cook begins preparing an order with highly toxic chemicals, illustrating the perils faced by those working in this illicit trade. Despite their protective gear, the cooks rely solely on surgical masks and exhibit noticeable physical reactions to the exposure, showcasing the grave risks associated with the drug manufacturing process.The region of Sinaloa has become increasingly volatile, suffering from a resurgence of violence as different factions of the cartel engage in bitter rivalry. Reports indicate this conflict has resulted in significant loss of life and economic strain on local businesses, prompting government interventions including military deployments and mass arrests.Culiacán is known as the heart of the Sinaloa cartel's operations, and this peak into its inner workings underscores the harsh realities of drug production amidst ongoing turmoil. As the battle for control continues, the implications on both a local and national scale remain profound.

Topics

More on this story